Plasma4Life: A Multi-Stakeholder Model for Sustainable Access to Plasma-Derived Medicinal Products

Plasma-derived medicinal products are essential therapies for people living with primary immunodeficiencies, bleeding disorders, neurological conditions and other rare or chronic diseases. Yet sustainable access depends on a complex ecosystem linking donors, blood and plasma services, manufacturers, clinicians, patients and policymakers. In many settings, fragmented knowledge, regulatory and data gaps, limited awareness of the plasma value chain, and insufficient opportunities for structured dialogue impede long-term planning. These challenges cannot be addressed through supply-side interventions alone. Plasma4Life, led by the United Nations Institute for Training and Research (UNITAR), was established to strengthen health systems by connecting evidence, capacity development and multi-stakeholder cooperation. This presentation examines whether a neutral convening model can translate global knowledge into locally owned priorities, practical recommendations and greater policy readiness for sustainable access to PDMPs.